Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Selecta Biosciences
Watertown, Massachusetts, United Statesselectabio.com ↗
- Ownership
- Public · SELB
- Employees
- ~200
- Development stage
- Other
01
Overview
Selecta’s lead program SEL‑212 reached Phase 3 trials for chronic refractory gout. The company’s ImmTOR™ platform has shown promise in inducing immune tolerance to enable repeat dosing of gene therapies and improve outcomes for autoimmune indications. In late 2023, Selecta merged with Cartesian Therapeutics; the combined company now focuses on pioneering RNA cell therapy for autoimmune disease, advancing programs such as Descartes‑08 in myasthenia gravis
- Therapeutic areas
- ImmunologyRare DiseasesRheumatology
- Modalities
- Nanoparticle immunomodulatory drugsGene therapies (AAV-based)Enzyme therapiesRNA cell therapy (post-merger focus)
- Industry
- Biotech
02
Partnerships
Asklepios BioPharmaceutical, Inc. (“AskBio”)—strategic partnership combining AAV gene therapy platformsAstellas Gene Therapies—license agreement for Xork IgG protease candidate targeting Pompe disease
Beyond the preview
Go deeper on Selecta Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Selecta Biosciences.